The inhibitor also inactivated 18 out of the 24 most common KRAS mutants found in cancer, when the latter were individually expressed in human embryonic kidney 293 (HEK293) cells (Fig. 4b and Extended Data Fig. 6a). The gene discussed is KRAS; the disease is cancer.